New SEC Form D filing
Forecast Bio, Inc., 2026-08-27
A new SEC Form D private-offering notice from San Francisco, CA, a $3,150,000 filer-stated offering target in Biotech. The source filing is one click away.
What this filing says
AI powered preclinical platform linking cellular neurobiology to mental health drug development outcomes
Filed 2026-08-27Filed to raise $3,150,000First money in 2025-11-11Raised so far $2,400,000HQ (as filed) San Francisco, CASector Biotech web-verified against the company’s own siteStage (inferred) SeedCall status Late filing
Source linked the Form D on EDGAR↗Website verified forecast.bio↗Named in the filing 1 executive & director
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- APOLLO AI LAB, CO., 2026-08-28, San Francisco, CA
- Monocacy Therapeutics Inc., 2026-08-28, $150K, Monrovia, MD
- Electric Pickle OpCo LLC, 2026-08-28, $1.5M, Hawthorne, CA
- Aegle Therapeutics Corp, 2026-08-28, $2.3M, Woburn, MA
- Castelion Corp, 2026-08-28, $800M, Torrance, CA
- DalCor Pharmaceuticals US, LLC, 2026-08-28, $7M, Sarasota, FL
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.